Revealing the role of regulatory b cells in cancer: development, function and treatment significance-Reference-Cited by-同舟云学术

Revealing the role of regulatory b cells in cancer: development, function and treatment significance

Published:2025-02-25 Issue:4 Volume:74 Page:
ISSN:1432-0851
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Ye Ruyu,Li Sijia,Li Yuxiao,Shi Kaixin,Li Li

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00262-025-03973-w.pdf

Reference179 articles.

1. Katz SI, Parker D, Turk JL (1974) B-cell suppression of delayed hypersensitivity reactions. Nature 251(5475):550–551

2. Aybar LT et al (2015) Reduced CD5(+) CD24(hi) CD38(hi) and interleukin-10(+) regulatory B cells in active anti-neutrophil cytoplasmic autoantibody-associated vasculitis permit increased circulating autoantibodies. Clin Exp Immunol 180(2):178–188

3. Cencioni MT et al (2021) Defective CD19+CD24(hi)CD38(hi) transitional B-cell function in patients with relapsing-remitting MS. Mult Scler 27(8):1187–1197

4. Fang Q et al (2020) CD19(+)CD24(hi)CD38(hi) regulatory B cells: a potential immune predictive marker of severity and therapeutic responsiveness of hepatitis C. Am J Transl Res 12(3):889–900

5. Gu Y et al (2020) Characterization of CD19(+) CD24(hi) CD38(hi) B cells in Chinese adult patients with atopic dermatitis. J Eur Acad Dermatol Venereol 34(12):2863–2870

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiomic Model Associated with Tumor Microenvironment Predicts Immunotherapy Response and Prognosis in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma;Research;2025-01